MYGN   $27.17  -4.09% Market Open

Myriad Genetics Inc
Total Cash 97.30M
totalCashPerShare 1.071
EBITDA -49.00M
Total Debt 143.30M
quickRatio 1.445
currentRatio 1.958
Total Revenue 802.20M
debtToEquity 19.352
Revenue/Share 9.2
ROA -0.05683
ROE -0.21034001
grossProfits
freeCashflow -102.36M
operatingCashflow -92.80M
earningsGrowth
revenueGrowth 0.153
grossMargins 0.69073
ebitdaMargins -0.061079998
operatingMargins -0.11773
profitMargins -0.19347
enterpriseValue 2.55B
forwardPE 106.11539
floatShares 83.24M
sharesOutstanding 90.82M
sharesShort 3.94M
sharesShortPriorMonth 4.39M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.02%
heldPercentInstitutions 1.04%
Short Ratio help_outline 5.74%
shortPercentOfFloat 0.06%
impliedSharesOutstanding
bookValue 8.146
Price To Book help_outline 3.39
earningsQuarterlyGrowth
netIncomeToCommon -155.20M
trailingEps -1.77%
forwardEps 0.26%
enterpriseToEbitda -52.08
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.02 3Q 2024
institutionsCount 318
lastUpdated Sept. 16, 2024, 11:22 a.m.